Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 3—March 2023
Synopsis

Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France

Claire TinévezComments to Author , Philippe Lehours, Anne-Gaëlle Ranc, Yaniss Belaroussi, Fanny Velardo, Damien Dubois, Catherine Neuwirth, Hélène Pailhoriès, Marie Dorel, Genevieve Hery-Arnaud, Olivier Join-Lambert, Emmanuelle Gras, Stéphane Corvec, Cyrielle Codde, Damien Fournier, Hugo Boijout, Violaine Doat, Leslie Bouard, Anne-Sophie Lagneaux, Maxime Pichon, Célia Couzigou, Claire Letellier, Adrien Lemaignen, Emmanuelle Bille, Xavier Bérard, Caroline Caradu, Claire Webster, Didier Neau, Charles Cazanave, Mathilde Puges, and the Campylobacteremia Study Group
Author affiliations: Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (C. Tinévez, P. Lehours, Y. Belaroussi, X. Bérard, C. Caradu, D. Neau, C. Cazanave, M. Puges); Centre Hospitalier Universitaire de Lyon, Lyon, France (A.-G. Ranc); Institut National de la Santé et de la Recherche Médicale, Bordeaux (F. Velardo); Centre Hospitalier Universitaire de Toulouse, Toulouse, France (D. Dubois); Centre Hospitalier Universitaire de Dijon, Dijon, France (C. Neuwirth); Centre Hospitalier Universitaire d’Angers, Angers, France (H. Pailhoriès); Centre Hospitalier Universitaire de Rennes, Rennes, France (M. Dorel); Centre Hospitalier Universitaire de Brest, Brest, France (G. Héry-Arnaud); Centre Hospitalier Universitaire de Caen, Caen, France (O. Join-Lambert); Hôpital Européen Georges–Pompidou, Paris, France (E. Gras); Centre Hospitalier Universitaire de Nantes, Nantes, France (S. Corvec); Centre Hospitalier Universitaire de Limoges, Limoges, France (C. Codde); Centre Hospitalier Universitaire de Besançon, Besançon, France (D. Fournier); Centre Hospitalier de Tarbes, Tarbes, France (H. Boijout); Centre Hospitalier Pierre Oudot, Bourguoin-Jallieu, France (V. Doat); Centre Hospitalier Départemental de Vendée, La Roche-Sur-Yon, France (L. Bouard); Centre Hospitalier Universitaire de Nancy, Nancy, France (A.-S. Lagneaux); Centre Hospitalier Universitaire de Poitiers, Poitiers, France (M. Pichon); Centre Hospitalier de Rodez, Rodez, France (C. Couzigou); Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France (C. Letellier); Centre Hospitalier Universitaire de Tours, Tours, France (A. Lemaignen); Centre Hospitalier de Necker-Enfants Malades, Paris (E. Bille); Imperial College London, London, UK (C. Webster)

Main Article

Table 1

Characteristics of 45 patients with Campylobacter spp. vascular infections in a multicenter retrospective study on vascular infections and endocarditis caused by Campylobacter spp., France*

Characteristic Vascular infection Native vascular infection Vascular graft or endograft infection
All patients
45 (100)
30 (66.7)
15 (33.3)
Age, y, median (interquartile range)
69.5 (61.2–81.3)
69.5 (61.8–81.3)
70 (62–81)
Sex
M 36 (80) 23 (76.7) 13 (86.7)
F
9 (20)
7 (23.3)
2 (13.3)
Localization
Aortic 30 (66.7) 17 (56.7) 13 (86.7)
Peripheral artery 7 (15.6) 6 (20) 1 (6.7)
Venous involvement 5 (11.1) 4 (13.3) 1 (6.7)
Lymphatic involvement 1 (2.2) 1 (3.3) 0
Not available
2 (4.4)
2 (6.7)
0
Underlying condition
Preexisting aortic aneurysm 11 (24.4) 9 (30) 2 (13.3)
Ischemic cardiomyopathy 10 (22.2) 8 (26.7) 2 (13.3)
Tobacco use 12 (26.7) 8 (26.7) 4 (26.7)
Chronic liver disease 5 (11.1) 4 (13.3) 1 (3.3)
Diabetes 11 (24.4) 8 (26.7) 3 (20)
Chronic renal failure 9 (20) 5 (16.7) 4 (26.7)
Hematologic malignancy 2 (4.4) 2 (6.7) 0
Solid neoplasm 11 (24.4) 6 (20) 5 (33.3)
Immunodeficiency
7 (15.6)
6 (20)
1 (6.7)
Clinical manifestations†
   Fever 32 (71.1) 24 (80) 8 (53.3)
   Septic shock 1 (2.2) 1 (3.3) 0
   Hemorrhagic shock 4 (8.9) 3 (10) 1 (6.7)
   Diarrhea 10 (22.2) 6 (20) 4 (26.7)
   Gastrointestinal bleeding 6 (13.3) 5 (16.7) 1 (3.3)
   Abdominal or lumbar pain 23 (51.1) 16 (53.3) 7 (46.7)
   Acute limb ischemia 3 (6.7) 3 (10) 0
   Osteoarticular involvement
4 (8.9)
2 (6.7)
2 (13.3)
Campylobacter species
C. fetus 36 (80) 23 (76.7) 13 (86.7)
C. jejuni 5 (11.1) 4 (13.3) 1 (3.3)
Other Campylobacter spp. 4 (8.9) 3 (10) 1 (3.3)

*Values are no. (%) except as indicated. †Signs and symptoms occurring within the past month were considered.

Main Article

Page created: December 31, 2022
Page updated: October 13, 2023
Page reviewed: October 13, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external